Interleukin-6 is a Strong Predictor of the Frequency of COPD Exacerbation Within 1 Year

References

• Lopez-Campos JL, Soler-Cataluna JJ, Miravitlles M. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2019 report: future challenges. Arch Bronconeumol. 2020;56(2):65–67. doi:10.1016/j.arbres.2019.06.001
   PubMed Web of Science ®Google Scholar
• Collaborators GBDCoD. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–1210.
   PubMed Web of Science ®Google Scholar
• Disease GIfCOL. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2020 report. Available from: https://goldcopd.org/gold-reports/. Accessed November 9, 2019.
   Google Scholar
• Agusti A, Edwards LD, Rennard SI, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012;7(5):e37483. doi:10.1371/journal.pone.0037483
   PubMed Web of Science ®Google Scholar
• Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379(9823):1341–1351. doi:10.1016/S0140-6736(11)60968-9
   PubMed Web of Science ®Google Scholar
• Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):a016295. doi:10.1101/cshperspect.a016295
   PubMed Web of Science ®Google Scholar
• Ataie-Kachoie P, Pourgholami MH, Morris DL. Inhibition of the IL-6 signaling pathway: a strategy to combat chronic inflammatory diseases and cancer. Cytokine Growth Factor Rev. 2013;24(2):163–173. doi:10.1016/j.cytogfr.2012.09.001
   PubMed Web of Science ®Google Scholar
• Rincon M, Irvin CG. Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci. 2012;8(9):1281–1290. doi:10.7150/ijbs.4874
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TA, Patel IS, et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest. 2005;128(4):1995–2004. doi:10.1378/chest.128.4.1995
   PubMed Web of Science ®Google Scholar
• Grubek-Jaworska H, Paplinska M, Hermanowicz-Salamon J, et al. IL-6 and IL-13 in induced sputum of COPD and asthma patients: correlation with respiratory tests. Respiration. 2012;84(2):101–107. doi:10.1159/000334900
   PubMed Web of Science ®Google Scholar
• Celli BR, Locantore N, Yates J, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(10):1065–1072. doi:10.1164/rccm.201110-1792OC
   PubMed Web of Science ®Google Scholar
• Ferrari R, Tanni SE, Caram LM, Correa C, Correa CR, Godoy I. Three-year follow-up of interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease. Respir Res. 2013;14:24. doi:10.1186/1465-9921-14-24
   PubMed Web of Science ®Google Scholar
• Wu X, Yuan B, Lopez E, Bai C, Wang X. Gene polymorphisms and chronic obstructive pulmonary disease. J Cell Mol Med. 2014;18(1):15–26. doi:10.1111/jcmm.12159
   PubMed Web of Science ®Google Scholar
• Pavord ID, Jones PW, Burgel PR, Rabe KF. Exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2016;11(Spec Iss):21–30.
   PubMedGoogle Scholar
• Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16(5):448–457. doi:10.1038/ni.3153
   PubMed Web of Science ®Google Scholar
• Unver N, McAllister F. IL-6 family cytokines: key inflammatory mediators as biomarkers and potential therapeutic targets. Cytokine Growth Factor Rev. 2018;41:10–17. doi:10.1016/j.cytogfr.2018.04.004
   PubMed Web of Science ®Google Scholar
• Su B, Liu T, Fan H, et al. Inflammatory markers and the risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. PLoS One. 2016;11(4):e0150586. doi:10.1371/journal.pone.0150586
   PubMed Web of Science ®Google Scholar
• Zeng YY, Hu WP, Zuo YH, Wang XR, Zhang J. Altered serum levels of type I collagen turnover indicators accompanied by IL-6 and IL-8 release in stable COPD. Int J Chron Obstruct Pulmon Dis. 2019;14:163–168. doi:10.2147/COPD.S188139
   PubMed Web of Science ®Google Scholar
• Gorska K, Nejman-Gryz P, Paplinska-Goryca M, Korczynski P, Prochorec-Sobieszek M, Krenke R. Comparative Study of IL-33 and IL-6 levels in different respiratory samples in mild-to-moderate asthma and COPD. COPD. 2018;15(1):36–45. doi:10.1080/15412555.2017.1416074
   PubMedGoogle Scholar
• Ghobadi H, Fouladi N, Beukaghazadeh K, Ansarin K. Association of high sensitive CRP level and COPD assessment test scores with clinically important predictive outcomes in stable COPD patients. Tanaffos. 2015;14(1):34–41.
   PubMedGoogle Scholar
• Nillawar AN, Bardapurkar JS, Bardapurkar SJ. High sensitive C-reactive protein as a systemic inflammatory marker and LDH-3 isoenzyme in chronic obstructive pulmonary disease. Lung India. 2012;29(1):24–29. doi:10.4103/0970-2113.92358
   PubMedGoogle Scholar
• Koo HK, Kang HK, Song P, Park HK, Lee SS, Jung H. Systemic white blood cell count as a biomarker associated with severity of chronic obstructive lung disease. Tuberc Respir Dis. 2017;80(3):304–310.
   PubMed Web of Science ®Google Scholar
• Bafadhel M, Pavord ID, Russell REK. Eosinophils in COPD: just another biomarker? Lancet Respir Med. 2017;5(9):747–759. doi:10.1016/S2213-2600(17)30217-5
   PubMed Web of Science ®Google Scholar
• Bilir B, Altıntaş N, Aydın M, Oran M, Özsu S, Tutar Ü. The predictive role of neutrophil to lymphocyte ratio in chronic obstructive pulmonary disease. Eur J Gen Med. 2016;13(2):105–110.
   Google Scholar
• Hirota N, Martin JG. Mechanisms of airway remodeling. Chest. 2013;144(3):1026–1032. doi:10.1378/chest.12-3073
   PubMed Web of Science ®Google Scholar
• Luna JM, Moon YP, Liu KM, et al. High-sensitivity C-reactive protein and interleukin-6-dominant inflammation and ischemic stroke risk: the northern Manhattan study. Stroke. 2014;45(4):979–987. doi:10.1161/STROKEAHA.113.002289
   PubMed Web of Science ®Google Scholar